Biotech & MedTech News
-
Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
August 9, 2023 (Source) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences…
-
Hemostemix Submits Its Retrospective Heart Study to Leading Stem Cell Journal and Has Prepared Its CLI Phase II Clinical Trial Manuscript for Peer Review
August 8, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it…
-
Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market
August 8, 2023 (Source) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences…
-
Zentek and McMaster University Announce New Aptamer Technology Platform
July 27, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), a technology development and commercialization company and…
-
Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential
July 20, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), a technology development and commercialization company, is…
-
Zentek Announces Updates to Senior Management Team
July 13, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company,…
-
Zentek Reports on Annual Financial Statements and Audit Committee
June 29, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK);(TSXV:ZEN), a graphene technology development and commercialization company…
-
Cardiol Therapeutics Reports Results of 2023 Annual General Meeting
June 29, 2023 (Source) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage…
-
Hemostemix Closes $403,539 of the Unit Private Placement
June 28, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it…
-
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT
June 27, 2023 (Source) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage…
